Search

Following the appointment of Anne Glover as first European Commission’s Chief Scientific Adviser in January 2012, President Barroso announced yesterday (27 February) the creation of the Science and Technology Advisory Council.

The possibility of a new EU/US free-trade agreement has been welcomed as likely to benefit research and research-intensive companies. However, it will need to overcome significant reservations in the European Parliament

Europe’s attempt to unify rules on clinical trials in the 2001 Directive is widely acknowledged to be a disaster. After years of debate, the Commission’s proposals for reform are getting a favourable reception, but it is critical the new regulation takes account of emerging technologies

Are buildings that consume less energy really more energy efficient as a result? Researcher Scott Kelly from the University of Cambridge explains how predicting energy efficiency is easier said than done, especially once human behaviour becomes part of the calculation.

BP’s new International Centre for Advanced Materials with its hub at Manchester University now has ten research projects underway across four universities — including one focused on smart “self-healing” coatings

The European Commission has launched a new strategy to enhance the competitiveness of European manufacturing by securing better access to raw materials

Third generation cognitive computing is making sense of data mountains and starting to deliver remarkable improvements in healthcare. Now, sensitively calibrated data protection rules are needed – to reassure patients and protect privacy, whilst allowing progress to continue

There's less for Horizon 2020 than the €80B the Commission proposed, though R&D will get more money than in FP7. With smoke and mirrors obscuring the true figures, MEPs say the real negotiations start now

Winners of European Research Council Proof-of-Concept grants showcased scientific breakthroughs and pitched their market potential to investors at a Science|Business Innovation Board event this week

As the Council meets to continue negotiating the budget for 2014 – 2020, senior industrialists, R&D administrators, university vice chancellors, Nobel prize winners and grass roots scientists insist the proposed €80B Horizon 2020 budget must be approved

It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton